The next frontier in gene therapys promise
Two University of Cincinnati and Cincinnati Childrens Hospital researchers have received an Advanced Manufacturing Development Grant (AMD) from the National Institutes of Health totaling 4 million to increase the use of innovations using gene delivery instead of radical genome editing.
Parker Chan PhD director of the UC College of Medicines Center for Affective Neuroscience and Jayanthi Lakshmanan an advanced biomedical studies professor at UC received the grants for their study on the use of salvage RNA (iRN) transcription factor-mediated repair-independent replacement (ReMR) to therapeutically target the recordable ANP1 gene in clinical bipolar disorder and those with Head and Neck tumors. They were awarded from the NIHs National Institute of Allergy and Infectious Diseases (NIH-NIHAN) Joint Investigator Program.